Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20030216769 A1
Publication typeApplication
Application numberUS 10/150,547
Publication dateNov 20, 2003
Filing dateMay 17, 2002
Priority dateMay 17, 2002
Also published asUS7434578, US7842061, US7875048, US8257381, US8956319, US9358013, US20040143282, US20040167636, US20050033344, US20110079221, US20120289989, US20160008002
Publication number10150547, 150547, US 2003/0216769 A1, US 2003/216769 A1, US 20030216769 A1, US 20030216769A1, US 2003216769 A1, US 2003216769A1, US-A1-20030216769, US-A1-2003216769, US2003/0216769A1, US2003/216769A1, US20030216769 A1, US20030216769A1, US2003216769 A1, US2003216769A1
InventorsDavid Dillard, Hugo Gonzalez, Seung Yi, Lauri DeVore, Mia Park, Dean Corcoran, Jenni Rimbaugh
Original AssigneeDillard David H., Gonzalez Hugo X., Seung Yi, Devore Lauri J., Mia Park, Corcoran Dean T., Jenni Rimbaugh
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Removable anchored lung volume reduction devices and methods
US 20030216769 A1
Abstract
An intra-bronchial device placed and anchored in an air passageway of a patient to collapse a lung portion associated with the air passageway. The device includes a support structure, an obstructing member carried by the support structure that reduces ventilation to the lung portion by preventing air from being inhaled into the lung portion, and at least one anchor carried by the support structure that anchors the obstruction device within the air passageway. The anchor may engage the air passageway wall by piercing or friction, include a stop dimensioned for limiting the piercing of the air passageway wall, and may be releasable from the air passageway for removal of the intra-bronchial device. The anchors may be carried by a peripheral portion of the support structure, or by a central portion of the support structure. The obstructing member may be a one-way valve.
Images(12)
Previous page
Next page
Claims(31)
What is claimed is:
1. An intra-bronchial device for placement in an air passageway of a patient to collapse a lung portion associated with the air passageway, the device comprising:
a support structure;
an obstructing member carried by the support structure that prevents air from being inhaled into the lung portion to collapse the lung portion; and
at least one anchor carried by the support structure that anchors the obstruction device within the air passageway when the anchor is deployed.
2. The intra-bronchial device of claim 1, wherein at least one anchor has an anchoring end that engages the air passageway wall.
3. The intra-bronchial device of claim 1, wherein the obstructing member and at least one anchor are simultaneously deployable.
4. The intra-bronchial device of claim 1, wherein at least one anchor is releasable from the air passageway for removal of the intra-bronchial device.
5. The intra-bronchial device of claim 1, wherein at least one anchor pierces into the air passageway wall.
6. The intra-bronchial device of claim 1, wherein at least a portion of the support structure is collapsible.
7. The intra-bronchial device of claim 1, wherein at least one anchor includes a stop dimensioned for limiting the piercing of the air passageway wall.
8. The intra-bronchial device of claim 1, wherein at least one anchor is configured to move from a first configuration to a second configuration to engage the air passageway.
9. The intra-bronchial device of claim 1, wherein at least one anchor is configured to move from a first configuration to a second configuration to engage the air passageway, and to move from the second configuration to the first configuration to disengage the air passageway.
10. The intra-bronchial device of claim 1, wherein at least one anchor is configured to move from a first configuration to a second configuration to engage the air passageway, and to move from the second configuration to a third configuration to disengage the air passageway.
11. The intra-bronchial device of claim 1, wherein the support structure is configured to urge at least one anchor to engage the air passageway wall.
12. The intra-bronchial device of claim 1, wherein the anchor includes a resilient material for imparting a force against the air passageway to deform the air passageway to more positively anchor the obstructing member.
13. The intra-bronchial device of claim 1, wherein the anchor includes at least one pad that frictionally engages the air passageway.
14. The intra-bronchial device of claim 1, wherein the obstructing member is a one-way valve.
15. The intra-bronchial device of claim 1, wherein at least one anchor is carried by a peripheral portion of the support structure.
16. The intra-bronchial device of claim 1, wherein at least one anchor is carried by a central portion of the support structure.
17. The intra-bronchial device of claim 1, wherein the obstructing member is releasable from the support structure and removable from the air passageway.
18. The intra-bronchial device of claim 1, wherein at least one anchor is carried distal to the obstructing member.
19. The intra-bronchial device of claim 1, wherein at least one anchor is carried proximal to the obstructing member.
20. The intra-bronchial device of claim 1, wherein at least one anchor is carried distal to the obstructing member and at least one anchor is carried proximal to the obstructing member.
21. A method of reducing the size of a lung by collapsing a portion of the lung, the method including the steps of:
providing an intra-bronchial device comprising a support structure, an obstructing member carried by the support structure which is so dimensioned when deployed in an air passageway communicating with the portion of the lung to be collapsed to preclude air from being inhaled, and at least one anchor carried by the support structure that anchors the obstructing member when the anchor is deployed;
placing the obstructing member in the air passageway; and
deploying at least one anchor.
22. The method of claim 21, wherein at least one anchor is releasable for removal of the intra-bronchial device.
23. The method of claim 21, wherein the obstructing member forms a one-way valve.
24. The method of claim 21, wherein at least a portion of the support structure is collapsible.
25. A method of reducing the size of a lung by collapsing a portion of the lung with a removable device, the method including the steps of:
providing an intra-bronchial device comprising a support structure, an obstructing member carried by the support structure which is so dimensioned when deployed in an air passageway communicating with the portion of the lung to be collapsed to preclude air from being inhaled, and at least one anchor carried by the support structure that anchors the obstructing member when the anchor is deployed;
placing the obstructing member in the air passageway;
deploying at least one anchor; and
removing at least the obstructing member.
26. The method of claim 25, wherein at least one anchor is releasable from the air passageway for removal of the intra-bronchial device, and the step of removing at least the obstructing member includes releasing at least one anchor.
27. The method of claim 25, wherein at least a portion of the obstructing member is releasable from the support structure, and the step of removing at least the obstructing member includes releasing the obstructing member from the support structure.
28. The method of claim 25, wherein the obstructing member forms a one-way valve.
29. The method of claim 25, wherein at least a portion of the support structure is collapsible.
30. An air passageway obstructing device comprising:
frame means for forming a support structure;
flexible membrane means for obstructing air flow within the air passageway, carried by the support structure; and
anchoring means to anchor the air passageway obstructing device, carried by the support structure,
the frame means being expandable to an expanded state within an air passageway to support the membrane means and the anchoring means, the anchoring means being releasable for removal of the device from the air passageway.
31. The intra-bronchial device of claim 1, wherein the support structure comprises material having memory of an original shape, and resiliency to return the material to that shape.
Description
    BACKGROUND
  • [0001]
    The present invention is generally directed to a removable anchored device, system, and method for treating Chronic Obstructive Pulmonary Disease (COPD). The present invention is more particularly directed to providing an anchored intra-bronchial obstruction that may be removable.
  • [0002]
    COPD has become a major cause of morbidity and mortality in the United States over the last three decades. COPD is characterized by the presence of airflow obstruction due to chronic bronchitis or emphysema. The airflow obstruction in COPD is due largely to structural abnormalities in the smaller airways. Important causes are inflammation, fibrosis, goblet cell metaplasia, and smooth muscle hypertrophy in terminal bronchioles.
  • [0003]
    The incidence, prevalence, and health-related costs of COPD are on the rise. Mortality due to COPD is also on the rise. In 1991, COPD was the fourth leading cause of death in the United States and had increased 33% since 1979. COPD affects the patient's whole life. It has three main symptoms: cough; breathlessness; and wheeze. At first, breathlessness may be noticed when running for a bus, digging in the garden, or walking uphill. Later, it may be noticed when simply walking in the kitchen. Over time, it may occur with less and less effort until it is present all of the time. COPD is a progressive disease and currently has no cure. Current treatments for COPD include the prevention of further respiratory damage, pharmacotherapy, and surgery. Each is discussed below.
  • [0004]
    The prevention of further respiratory damage entails the adoption of a healthy lifestyle. Smoking cessation is believed to be the single most important therapeutic intervention. However, regular exercise and weight control are also important. Patients whose symptoms restrict their daily activities or who otherwise have an impaired quality of life may require a pulmonary rehabilitation program including ventilatory muscle training and breathing retraining. Long-term oxygen therapy may also become necessary.
  • [0005]
    Pharmacotherapy may include bronchodilator therapy to open up the airways as much as possible or inhaled beta-agonists. For those patients who respond poorly to the foregoing or who have persistent symptoms, ipratropium bromide may be indicated. Further, courses of steroids, such as corticosteroids, may be required. Lastly, antibiotics may be required to prevent infections and influenza and pneumococcal vaccines may be routinely administered. Unfortunately, there is no evidence that early, regular use of pharmacotherapy will alter the progression of COPD.
  • [0006]
    About 40 years ago, it was first postulated that the tethering force that tends to keep the intrathoracic airways open was lost in emphysema and that by surgically removing the most affected parts of the lungs, the force could be partially restored. Although the surgery was deemed promising, the lung volume reduction surgery (LVRS) procedure was abandoned. LVRS was later revived. In the early 1990's, hundreds of patients underwent the procedure. However, the procedure fell out of favor when Medicare stopped reimbursing for LVRS. Unfortunately, data is relatively scarce and many factors conspire to make what data exists difficult to interpret. The procedure is currently under review in a controlled clinical trial. However, what data does exist tends to indicate that patients benefited from the procedure in terms of an increase in forced expiratory volume, a decrease in total lung capacity, and a significant improvement in lung function, dyspnea, and quality of life. Improvements in pulmonary function after LVRS have been attributed to at least four possible mechanisms. These include enhanced elastic recoil, correction of ventilation/perfusion mismatch, improved efficiency of respiratory musculature, and improved right ventricular filling.
  • [0007]
    Lastly, lung transplantation is also an option. Today, COPD is the most common diagnosis for which lung transplantation is considered. Unfortunately, this consideration is given for only those with advanced COPD. Given the limited availability of donor organs, lung transplant is far from being available to all patients.
  • [0008]
    There is a need for additional non-surgical options for permanently treating COPD. A promising new therapy includes non-surgical apparatus and procedures for lung volume reduction by permanently obstructing the air passageway that communicates with the portion of the lung to be collapsed. The therapy includes placing an obstruction in the air passageway that prevents inhaled air from flowing into the portion of the lung to be collapsed. Lung volume reduction with concomitant improved pulmonary function may be obtained without the need for surgery. The effectiveness of obstructions may be enhanced if it is anchored in place. The effectiveness may also be enhanced if the obstruction is removable. However, no readily available apparatus and method exists for anchoring the obstruction, and for removal if required.
  • [0009]
    In view of the foregoing, there is a need in the art for a new and improved apparatus and method for permanently obstructing an air passageway that is anchored in place, and that may be removed if required. The present invention is directed to a device, system, and method that provide such an improved apparatus and method for treating COPD.
  • SUMMARY
  • [0010]
    The present invention provides an anchored intra-bronchial device for placement in an air passageway of a patient to collapse a lung portion associated with the air passageway. The device includes a support structure, an obstructing member carried by the support structure that prevents air from being inhaled into the lung portion to collapse the lung portion, and at least one anchor carried by the support structure that anchors the obstruction device within the air passageway when the anchor is deployed. The support structure, or a portion thereof, may be collapsible. The obstructing member and at least one anchor may be simultaneously deployable. The support structure may be configured to urge at least one anchor to engage the air passageway wall. The obstructing member may be a one-way valve. The obstructing member may be releasable from the support structure and removable from the air passageway.
  • [0011]
    In accordance with the present invention, alternative embodiments are provided for the anchors. An anchor may have an anchoring end that engages the air passageway wall, and that may pierce into the air passageway wall. An anchor may include a stop dimensioned for limiting the piercing of the air passageway wall. An anchor may include a resilient material for imparting a force against the air passageway to deform the air passageway to more positively anchor the obstructing member. An anchor may be releasable from the air passageway for removal of the intra-bronchial device. An anchor may include a pad that frictionally engages the air passageway. Further, an anchor may be configured to move from a first configuration to a second configuration to engage the air passageway. An anchor may be configured to move from a first configuration to a second configuration to engage the air passageway, and to move from the second configuration to the first configuration to disengage the air passageway. Alternatively, an anchor may be configured to move from a first configuration to a second configuration to engage the air passageway, and to move from the second configuration to a third configuration to disengage the air passageway.
  • [0012]
    In accordance with the present invention, alternative embodiments provide for the anchors to be carried on different portions of the device. An anchor may be carried by a peripheral portion of the support structure, and/or by a central portion of the support structure. An anchor may be carried distal to the obstructing member, and/or proximal to the obstructing member.
  • [0013]
    The present invention further provides a method of reducing the size of a lung, or reducing ventilation to a portion of a lung, by collapsing at least a portion of the lung. The method includes the step of providing an intra-bronchial device that includes a support structure, an obstructing member carried by the support structure which is so dimensioned when deployed in an air passageway communicating with the portion of the lung to be collapsed to preclude air from being inhaled, and at least one anchor carried by the support structure that anchors the obstructing member when the anchor is deployed. The method further includes the steps of placing the obstructing member in the air passageway, and deploying at least one anchor. An anchor may be releasable for removal of the intra-bronchial device. The obstructing member may form a one-way valve. The support structure may be collapsible.
  • [0014]
    The present invention yet further provides a method of reducing the size of a lung, or reducing ventilation to a portion of a lung, by collapsing a portion of the lung with a removable device. The method includes the step of providing an intra-bronchial device comprising a support structure, an obstructing member carried by the support structure which is so dimensioned when deployed in an air passageway communicating with the portion of the lung to be collapsed to preclude air from being inhaled, and at least one anchor carried by the support structure that anchors the obstructing member when the anchor is deployed. The method further includes the steps of placing the obstructing member in the air passageway, and deploying at least one anchor. The method further includes the step of removing at least the obstructing member. At least one anchor may be releasable from the air passageway for removal of at least the obstructing device, and the step of removing at least the obstructing device includes releasing at least one anchor. At least a portion of the obstructing member is releasable from the support structure, and the step of removing at least the obstructing member includes releasing the obstructing member from the support structure. The obstructing member may form a one-way valve. At least a portion of the support structure may be collapsible.
  • [0015]
    The present invention additionally provides an air passageway obstructing device. The device includes frame means for forming a support structure, flexible membrane means for obstructing air flow within the air passageway and carried by the support structure, and anchoring means to anchor the air passageway obstructing device, carried by the support structure. The frame means is expandable to an expanded state within an air passageway to support the membrane means and the anchoring means. The anchoring means is releasable for removal of the device from the air passageway.
  • [0016]
    These and various other features as well as advantages which characterize the present invention will be apparent from a reading of the following detailed description and a review of the associated drawings.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0017]
    The features of the present invention which are believed to be novel are set forth with particularity in the appended claims. The invention, together with further objects and advantages thereof, may best be understood by making reference to the following description taken in conjunction with the accompanying drawings, in the several figures of which like referenced numerals identify like elements, and wherein:
  • [0018]
    [0018]FIG. 1 is a simplified sectional view of a thorax illustrating a healthy respiratory system;
  • [0019]
    [0019]FIG. 2 is a sectional view similar to FIG. 1, but illustrating a respiratory system suffering from COPD and the execution of a first step in treating the COPD condition by reducing the size of a lung portion in accordance with the present invention;
  • [0020]
    [0020]FIG. 3 is perspective view, partially in section, and to an enlarged scale, illustrating an intermediate step in the treatment;
  • [0021]
    [0021]FIG. 4 is a perspective view of a conduit that may be utilized in practicing the present invention;
  • [0022]
    [0022]FIG. 5 is a perspective view of an intra-bronchial device, with anchors located proximally on peripheral portions of the support members, as the device would appear when fully deployed in an air passageway in accordance with the present invention;
  • [0023]
    [0023]FIG. 6 is a partial section view of the device of FIG. 5 showing additional details of the support structure;
  • [0024]
    [0024]FIG. 7 is a perspective view of the intra-bronchial device of FIG. 5 anchored in an air passageway;
  • [0025]
    [0025]FIG. 8 illustrates an intra-bronchial device, with anchors carried distally on the central support structure, fully deployed in an air passageway in accordance with an alternative embodiment of the invention;
  • [0026]
    [0026]FIG. 9 is a perspective view of an intra-bronchial device, with proximal anchors carried on the central support structure, in accordance with an alternative embodiment of the invention;
  • [0027]
    [0027]FIG. 10 is a side view of an intra-bronchial device, with proximal anchors carried on the central support structure, in accordance with an alternative embodiment of the invention;
  • [0028]
    [0028]FIG. 11 is an end view of an intra-bronchial device, with proximal anchors carried on the central support structure, in accordance with an alternative embodiment of the invention;
  • [0029]
    [0029]FIG. 12 is a perspective view of an intra-bronchial device, with distal friction anchors carried on the central support structure, in accordance with an alternative embodiment of the invention;
  • [0030]
    [0030]FIG. 13 is a side view of an intra-bronchial device, with distal friction anchors carried on the central support structure, in accordance with an alternative embodiment of the invention;
  • [0031]
    [0031]FIG. 14 is an end view of an intra-bronchial device, with distal friction anchors carried on the central support structure, in accordance with an alternative embodiment of the invention;
  • [0032]
    [0032]FIG. 15 is a perspective view of an intra-bronchial device similar to that of FIGS. 12-14 anchored in an air passageway;
  • [0033]
    [0033]FIG. 16 is a perspective view illustrating an alternative embodiment of a removable intra-bronchial device with proximal anchors carried on a peripheral portion of a plurality of support structure members in accord with the present invention;
  • [0034]
    [0034]FIG. 17 is a side view of the device of FIG. 16;
  • [0035]
    [0035]FIG. 18 is a perspective view illustrating an alternative embodiment of a removable intra-bronchial device with both distal and proximal anchors carried on corresponding peripheral portions of the central support structure in accord with the present invention; and
  • [0036]
    [0036]FIG. 19 is a side view of the device of FIG. 18.
  • DETAILED DESCRIPTION
  • [0037]
    In the following detailed description of exemplary embodiments of the invention, reference is made to the accompanying drawings that form a part hereof. The detailed description and the drawings illustrate how specific exemplary embodiments by which the invention may be practiced. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention. It is understood that other embodiments may be utilized, and other changes may be made, without departing from the spirit or scope of the present invention. The following detailed description is therefore not to be taken in a limiting sense, and the scope of the present invention is defined by the appended claims.
  • [0038]
    Throughout the specification and claims, the following terms take the meanings explicitly associated herein unless the context clearly dictates otherwise. The meaning of “a”, “an”, and “the” include plural references. The meaning of “in” includes “in” and “on.” Referring to the drawings, like numbers indicate like parts throughout the views. Additionally, a reference to the singular includes a reference to the plural unless otherwise stated or inconsistent with the disclosure herein.
  • [0039]
    Additionally, throughout the specification, claims, and drawings, the term “proximal” means nearest the trachea, and “distal” means nearest the bronchioles.
  • [0040]
    Briefly stated, an aspect of the invention provides an anchored intra-bronchial device for placement in an air passageway of a patient. The intra-bronchial device obstructs the air passageway, reducing the ventilation to a portion of the lung and/or collapsing the lung portion associated with the air passageway. A further aspect of the invention provides removability of the intra-bronchial device, either by releasing the anchors for removal of the entire device or by separating the obstructing member and removing it.
  • [0041]
    [0041]FIG. 1 is a sectional view of a healthy respiratory system. The respiratory system 20 resides within the thorax 22 that occupies a space defined by the chest wall 24 and the diaphragm 26.
  • [0042]
    The respiratory system 20 includes the trachea 28, the left mainstem bronchus 30, the right mainstem bronchus 32, the bronchial branches 34, 36, 38, 40, and 42 and sub-branches 44, 46, 48, and 50. The respiratory system 20 further includes left lung lobes 52 and 54 and right lung lobes 56, 58, and 60. Each bronchial branch and sub-branch communicates with a respective different portion of a lung lobe, either the entire lung lobe or a portion thereof. As used herein, the term “air passageway” is meant to denote either a bronchi or bronchiole, and typically means a bronchial branch or sub-branch which communicates with a corresponding individual lung lobe or lung lobe portion to provide inhaled air thereto or conduct exhaled air therefrom.
  • [0043]
    Characteristic of a healthy respiratory system is the arched or inwardly arcuate diaphragm 26. As the individual inhales, the diaphragm 26 straightens to increase the volume of the thorax 22. This causes a negative pressure within the thorax. The negative pressure within the thorax in turn causes the lung lobes to fill with air. When the individual exhales, the diaphragm returns to its original arched condition to decrease the volume of the thorax. The decreased volume of the thorax causes a positive pressure within the thorax which in turn causes exhalation of the lung lobes.
  • [0044]
    In contrast to the healthy respiratory system of FIG. 1, FIG. 2 illustrates a respiratory system suffering from COPD. Here it may be seen that the lung lobes 52, 54, 56, 58, and 60 are enlarged and that the diaphragm 26 is not arched but substantially straight. Hence, this individual is incapable of breathing normally by moving diaphragm 26. Instead, in order to create the negative pressure in thorax 22 required for breathing, this individual must move the chest wall outwardly to increase the volume of the thorax. This results in inefficient breathing causing these individuals to breathe rapidly with shallow breaths.
  • [0045]
    It has been found that the apex portions 62 and 66 of the upper lung lobes 52 and 56, respectively, are most affected by COPD. Hence, bronchial sub-branch obstructing devices are generally employed for treating the apex 66 of the right, upper lung lobe 56. However, as will be appreciated by those skilled in the art, the present invention may be applied to any lung portion without departing from the present invention. As will be further appreciated by those skilled the in art, the present invention may be used with any type of obstructing member to provide an anchored obstructing device, which may be removed. The inventions disclosed and claimed in U.S. Pat. Nos. 6,258,100 and 6,293,951, both of which are incorporated herein by reference, provide an improved therapy for treating COPD by obstructing an air passageway using an intra-bronchial valve or plug. The present invention may be used with the apparatus, system, and methods of these patents as will be briefly described in conjunction with the disclosure of the preferred embodiments of the present invention.
  • [0046]
    The insertion of an obstructing member treats COPD by deriving the benefits of lung volume reduction surgery without the need of performing the surgery. The treatment contemplates permanent collapse of a lung portion. This leaves extra volume within the thorax for the diaphragm to assume its arched state for acting upon the remaining healthier lung tissue. As previously mentioned, this should result in improved pulmonary function due to enhanced elastic recoil, correction of ventilation/perfusion mismatch, improved efficiency of respiratory musculature, and improved right ventricle filling., The present invention supports the use of intra-bronchial obstructions to treat COPD by anchoring the obstruction device in the air passageway. The present invention further supports the use of intra-bronchial obstructions by providing for their removal if necessary. Use of anchors can allow the obstructing member to be relatively loosely fitted against the air passageway wall, which may preserve mucociliary transport of mucus and debris out of the collapsed lung portion and allow distal mucus to be coughed.
  • [0047]
    [0047]FIG. 2 also illustrates a step in COPD treatment using an obstructing member. Treatment is initiated by feeding a conduit or catheter 70 down the trachea 28, into the right mainstem bronchus 32, into the bronchial branch 42 and into and terminating within the sub-branch 50. The sub-branch 50 is the air passageway that communicates with the lung portion 66 to be treated, and is also referred to herein as air passageway 50. The catheter 70 is preferably formed of flexible material such as polyethylene. Also, the catheter 70 is preferably preformed with a bend 72 to assist the feeding of the catheter from the right mainstem bronchus 32 into the bronchial branch 42.
  • [0048]
    [0048]FIG. 3 illustrates a further step in a method for placing an obstructing member 90 in a bronchial sub-branch using a catheter. The invention disclosed herein is not limited to use with the particular method illustrated herein. Catheter 70 includes an optional inflatable sealing member 74 for use with a vacuum to collapse lung portion 66 prior to insertion of obstructing member 90. The obstructing member 90 may be formed of resilient or collapsible material to enable the obstructing member 90 to be fed through the conduit 70 in a collapsed state. The stylet 92 is used to push the obstructing member 90 to the end 77 of the catheter 70 for placing the obstructing member 90 within the air passageway 50 adjacent to the lung portion 66 to be permanently collapsed. Optional sealing member 74 is withdrawn after obstructing member 90 is inserted.
  • [0049]
    Another step in placing an obstructing member 90 may include sizing the air passageway location where the obstructing member 90 will be positioned.
  • [0050]
    A function of the intra-bronchial device disclosed and claimed in this specification, including the detailed description and the claims, is described in terms of collapsing a lung portion associated with an air passageway. In some lungs, a portion of a lung may receive air from collateral air passageways. Obstructing one of the collateral air passageways may reduce the volume of the lung portion associated with the air passageway, but not completely collapse the lung portion, as that term may be generally understood. As used herein, the meaning of “collapse” includes both a complete collapse of a lung portion, and a partial collapse resulting in a marked decrease in the volume of a lung portion.
  • [0051]
    Once deployed, the obstructing member precludes inhaled air from entering the lung portion to be collapsed. In accordance with the present invention, it is preferable that the obstructing member takes the form of a one-way valve. In addition to precluding inhaled air from entering the lung portion, the member further allows air within the lung portion to be exhaled. This results in more rapid collapse of the lung portion. In addition, anchoring obstructing members that preclude both inhaled and exhaled airflow are contemplated as within the scope of the invention.
  • [0052]
    [0052]FIG. 4 illustrates the obstructing device in place within air passageway 50. Obstructing member 90 has expanded upon placement in the air passageway 50 to seal the air passageway 50. This causes the lung portion 66 to be maintained in a permanently collapsed state. The obstructing member 90 may be any shape suitable for accomplishing its purpose, and may be a solid material or a membrane.
  • [0053]
    More specifically, the obstructing member 90 has an outer dimension 91, and when expanded, enables a contact zone with the air passageway inner dimension 51. This seals the air passageway upon placement of the obstructing member 90 in the air passageway 50 for maintaining the lung portion 66 in the collapsed state.
  • [0054]
    Alternatively, the lung portion 66 may be collapsed using vacuum prior to placement of obstructing member 90, or sealing the air passageway 50 with obstructing member 90 may collapse it. The air within the lung portion 66 will be absorbed by the body over time, reducing the volume of and/or collapsing the lung portion 66. Alternatively, obstructing member 90 may include the function of a one-way valve that allows air to escape from lung portion 66. Lung portion 66 will then collapse, and the valve will prevent air from being inhaled.
  • [0055]
    [0055]FIG. 5 is a perspective view of an intra-bronchial device, with anchors located proximally on peripheral portions of the support members, as the device would appear when fully deployed in an air passageway in accordance with the present invention. Intra-bronchial device 100 includes a support structure 101, a central support structure 109; support members 102, 104, 106, and 108; anchors 112, 114, 116, and 118; anchor ends 122, 124, 126, and 128; and an obstructing member 110.
  • [0056]
    The support structure 101 of intra-bronchial device includes central support structure 109, and support members 102, 104, 106, and 108. The support members 102, 104, 106, and 108, carry anchors 112, 114, 116, and 118; and anchor ends 122, 124, 126, and 128, respectively. Central support structure 109 is a tubular member, preferably hypodermic needle tubing. Support members 102, 104, 106, and 108, are coupled mechanically to central support structure 109, such as by crimping, or by other methods such as adhesive or welding. Support members 102, 104, 106, and 108 are generally similar to each other. The support members are preferably formed of stainless steel, Nitinol, or other suitable material having a memory of its original shape, and resiliency to return the material to that shape.
  • [0057]
    Anchors 112, 114, 116, and 118 are extensions of support members 102, 104, 106, and 108. The anchors are formed by bending the support members to an angle that will result in a deployed anchor engaging the air passageway wall by piercing it approximately perpendicularly. In this preferred embodiment, the bend angle is approximately a right angle. Anchor ends 122, 124, 126, and 128 may be shaped to promote piercing the air passageway wall. In an alternative embodiment, the elements of support structure 101 may be formed by laser cutting a single piece of hypodermic needle tubing.
  • [0058]
    Obstructing member 110 is carried on the support structure 101, and includes a flexible membrane open in the proximal direction and which may be formed of silicone or polyurethane, for example. The obstructing member 110 is secured to the central support structure 109, and may be additionally secured to the support members at its larger diameter 91. It may be secured by adhesive, or other manner known in the art. Obstructing member 110 may be loosely carried on support members 102, 104, 106, and 108, such that it expands on inhalation to form a seal against a wall of the air passageway, and contracts on exhalation to allow air and mucociliary transport from the collapsed lung. This provides a one-way valve function.
  • [0059]
    [0059]FIG. 6 is a partial section view of the device of FIG. 5 showing additional detail of the support structure. The linear cross-section view of FIG. 6 exposes the arrangement of support members 106 and 108 in their deployed configuration. The details of support members 102 and 104 are omitted from FIG. 6 for clarity, but are the same as support members 106 and 108. The distal end of obstructing member 110 is carried on central support structure 109. Support members 106 and 108 are shown emanating from central support structure 109, and arranged to loosely support to obstructing member 110 at its larger diameter 91. This allows obstructing member 110 to expand on inhalation and seal at the contact zone (element 129 of FIG. 7), and to partially contract on exhalation to allow exhalation of air and mucociliary transport. In an alternative embodiment, support members 106 and 108 do not actively support obstructing member 110, and the expansion and contraction of obstructing member 110 is governed by its elasticity.
  • [0060]
    [0060]FIG. 7 is a perspective view of the intra-bronchial device of FIG. 5 anchored in an air passageway. Intra-bronchial device 100 is illustrated with anchors 112 and 116 piercing into the air passageway wall 130 of air passageway 50. This anchors the intra-bronchial device 100 in place.
  • [0061]
    Intra-bronchial device 100 is collapsible for insertion into an internal lumen of a catheter. At least the support members 102, 104, 106, and 108, and the obstructing member 110, may be collapsed. Intra-bronchial device 100 is inserted into the catheter lumen, which is typically already placed in the air passageway 50 as generally illustrated in FIG. 3. Using the stylet, intra-bronchial device 100 is advanced down the catheter lumen into the air passageway 50 to where the device is to be deployed. Once the point of deployment is reached, intra-bronchial device 100 is expelled from the catheter and assumes its deployed shape as illustrated in FIG. 5. Upon deployment, obstructing member 110 forms a contact zone 129 with the wall 130 of the air passageway 50 to prevent air from being inhaled into the lung portion to collapse the lung portion. Simultaneously upon deployment, the memory and resiliency of the support members 102, 104, 106, and 108 impart a force on the anchor ends 122, 124, 126, and 128, and urge the anchors 112, 114, 116, and 118 to engage air passageway wall 130 by piercing. The anchors pierce into and become embedded in the wall 130 of the air passageway 50, preferably without projecting through the wall 130. Stops may be incorporated into the anchors to limit piercing of the wall 130. For example, the bend between the support member and the anchor may form a stop.
  • [0062]
    The preclusion of air from being inhaled into the lung portion may be terminated by eliminating the obstructing effect of intra-bronchial device 100. The preclusion of air by the embodiment illustrated in FIGS. 5-7 may be eliminated by releasing anchors 112, 114, 116, and 118 from the air passageway wail 130. The anchors may be released by inserting a catheter into air passageway 50 in proximity to intra-bronchial device 100. A retractor device, such as biopsy forceps, capable of gripping a portion of intra-bronchial device 100 is inserted in the catheter. The forceps are used to engage a portion of the support structure 101 of intra-bronchial device 100, such as a support member or an anchor, or the obstructing member 110, and draw it toward the catheter. The drawing action releases anchors 112, 114, 116, and 118 from air passageway wall 130. The intra-bronchial device 110 is then drawn into the catheter with the forceps, causing the support structure 101 and obstructing member 110 to collapse. The collapsed device 100 now fully enters the catheter lumen for removal from the patient. Alternatively, the obstructing effect may be eliminated by grabbing the obstructing member 110, releasing it from the support structure 101, and removing obstructing member 110 from the patient.
  • [0063]
    [0063]FIG. 8 illustrates an intra-bronchial device, with anchors carried distally on the central support structure, fully deployed in an air passageway in accordance with an alternative embodiment of the invention. The anchors 112, 114, 116, and 118 of intra-bronchial device 140 are carried on portions of support members 102, 104, 106, and 108 distal of the central support structure 109. The support members are gathered together and carried by the central support structure 109. Other than the anchors 112, 114, 116, and 118 being formed and carried on distal portions of support members 102, 104, 106, and 108, intra-bronchial device 140 is substantially similar in construction, operation, and removal as the intra-bronchial device 100 of FIG. 5.
  • [0064]
    When intra-bronchial device 140 is compressed for insertion into the catheter lumen for placement in the air passageway, the anchors 112, 114, 116, and 118 are collapsed into a first configuration. In the first configuration, the anchor ends 122, 124, 126, and 128 are moved toward obstructing member 110, and anchors 112, 114, 116, and 118 thereby folded toward obstructing member 110. In an alternative embodiment, the anchor ends 122, 124, 126, and 128 are moved away from obstructing member 110, and anchors 112, 114, 116, and 118 thereby folded away from obstructing member 110.
  • [0065]
    When intra-bronchial device 100 is deployed from the catheter lumen, the memory and resiliency of the anchors 112, 114, 116, and 118 impart a force that moves the anchor ends 122, 124, 126, and 128 into a second configuration to engage air passageway wall 130. This is the deployed configuration illustrated in FIG. 8. For removal, drawing intra-bronchial device 140 toward the catheter causes the anchor ends 122, 124, 126, and 128 to move away from obstructing member 110 to a third configuration. Anchors 112, 114, 116, and 118 are thereby folded away from obstructing member 110 and are released from engagement with air passageway wall 130 for removal of the intra-bronchial device 140. In an alternative embodiment, the anchors 112, 114, 116, and 118 may be formed on additional support members carried by central support structure 109, instead of being formed from distal portions of support members 102, 104, 106, and 108.
  • [0066]
    FIGS. 9-11 illustrate an intra-bronchial device, with proximal anchors carried on the central support structure, in accordance with an alternative embodiment of the invention. FIG. 9 is a perspective view, FIG. 10 is a side view, and FIG. 11 is an end view of the device. Intra-bronchial device 150 is generally similar in construction, operation, placement, and removal to the intra-bronchial device 100 of FIG. 5. Its structure has six support members and three anchors, with anchor stops. Anchors 112, 114, and 116 include stops 152, 154, and 156 respectively. Intra-bronchial device 150 also includes an anchor base 161, an anchor base aperture 165, anchor base angle 163, and two additional support members 103 and 105.
  • [0067]
    Central support structure 109 extends both proximal and distal of obstructing member 110, and carries anchor base 161 proximal of obstructing member 110, carries anchors 112, 114, and 116, and includes anchor base aperture 165. The linear plane of anchors 112, 114, and 116 intersect anchor base 161 at anchor base angle 163. Anchor base angle 163 is selected to optimize anchor deployment force and anchor release. Stops 152, 154, and 156 include a flat area to limit the piercing of the air passageway wall by anchor ends 122, 124, and 126. In alternative embodiments, the stops can be any configuration or shape known to those skilled in the art to limit the piercing.
  • [0068]
    In operation, when intra-bronchial device 150 is compressed for insertion into the catheter lumen for placement in the air passageway, anchors 112, 114, and 116 are collapsed into a first configuration. In the first configuration, the anchor ends 122, 124, and 126 are moved toward obstructing member 110, thereby decreasing anchor base angle 163 and folding anchors 112, 114, and 116 toward obstructing member 110. The anchor ends and the anchors may be moved by sliding a catheter or hollow member over anchor base 161 and toward obstructing member 110. When intra-bronchial device 150 is deployed from the catheter lumen, the memory and resiliency of the anchors 112, 114, and 116, anchor angle 163, and anchor base 161 impart a force that moves the anchor members into a second configuration, which is the deployed configuration, to engage air passageway wall 130. The second or deployed configuration is illustrated in FIGS. 9-11. Stops 152, 154, and 156 limit the piercing of the air passageway wall by anchor ends 122, 124, and 126.
  • [0069]
    For removal, a retractor device is deployed from a catheter to engage anchor base 161 and restrain intra-bronchial device 150. Anchor base aperture 165 is arranged for being gripped by a retractor device. The retractor device may be a biopsy forceps to engage anchor base 161, or a hooked device to engage anchor base aperture 165. The retractor device is then used to draw intra-bronchial device 150 proximal, releasing the anchors 112, 114, and 116 from the air passageway wall. This collapses the anchors into to the first configuration for removal.
  • [0070]
    In an alternative step to collapse the anchors, after anchor base 161 or aperture 165 is engaged, a catheter may then moved distally over anchor base 161, and in contact with anchors 112, 114, and 116. The catheter is further moved against anchors 112, 114, and 116, while intra-bronchial device 150 is restrained at anchor base 161. This releases the anchors 112, 114, and 116 from the air passageway wall. This collapses the anchors into to the first configuration for removal.
  • [0071]
    Continuing with the removal steps, intra-bronchial device 150 is then further drawn into the catheter by pulling on the retractor device used to engage anchor base 161. This collapses support structure 101 and obstructing member 110 so that they may be fully drawn into the catheter. Once drawn into the catheter, intra-bronchial device 160 may be removed from the air passageway and the patient.
  • [0072]
    FIGS. 12-14 illustrate an intra-bronchial device, with distal friction anchors carried on the central support structure, in accordance with an alternative embodiment of the invention. FIG. 12 is a perspective view, FIG. 13 is a side view, and FIG. 14 is an end view. Intra-bronchial device 160 is generally similar in construction, placement, and operation to the intra-bronchial device 150 of FIGS. 9-11. Intra-bronchial device 160 is removed in the manner described in conjunction with FIG. 7. However, Intra-bronchial device 160 differs from intra-bronchial device 150 in that the structure includes four distal anchors with anchor ends 122, 124, 126, and 128 shaped into pads that deform and frictionally engage the air passageway wall to more positively anchor intra-bronchial device 160 without piercing. The structure also includes an obstructing member support base 170.
  • [0073]
    Central support structure 109 extends distal of obstructing member 110, and carries anchor base 161 distal of obstructing member 110. Anchor base 161 carries anchors 112, 114, 116, and 118. The linear plane of anchors 112, 114, 116, and 118 intersects anchor base 161 at anchor angle 163. Anchor angle 163 is selected to optimize anchor deployment force and anchor release. The anchors 112, 114, 116, and 118, and anchor base 161 may be constructed by laser cutting a single piece of hypodermic tubing lengthwise to form the anchors 112, 114, 116, and 118, and then bending the anchors to form anchor angle 163. Anchor base 161 is secured to central support structure 109. Support members 102, 103, 104, 105, 106, and 108, and the obstructing member support member base 170 may be constructed in a like manner. Obstructing member 110 is secured to the obstructing member support base 170, and alternatively to support members 102, 103, 104, 105, 106, and 108. The assembly of obstructing member 110 and support base 170 is secured to central support structure 109. Central support structure 109 may extend proximal of support member base 170 to provide a surface for gripping the intra-bronchial device 160 for removal, and may include an aperture to be engaged by a hooked device.
  • [0074]
    [0074]FIG. 15 is a perspective view of an intra-bronchial device similar to that of FIGS. 12-14 anchored in an air passageway. It illustrates pad-shaped anchor ends 122-128 of intra-bronchial device 180 deforming and frictionally engaging air passageway wall 130.
  • [0075]
    [0075]FIGS. 16 and 17 illustrate a removable intra-bronchial device with proximal anchors carried on a peripheral portion of a plurality of support structure members in accord with the present invention. FIG. 16 is a perspective view, as the device would appear when fully deployed in an air passageway. FIG. 17 is a side view of FIG. 16. In a preferred embodiment, the support structure 101 of intra-bronchial device 190 includes six support members, with two opposing pairs of support members carrying anchors and each member of a pair being joined together by a retracting member. Intra-bronchial device 190 includes a support structure 101 having a central support structure 109 and support members 102, 103, 104, 105, 106, and 108; four anchors 113, 114, 116, and 118 having anchor ends 123, 124, 126, and 128 respectively; two “U” shaped retracting members 192 and 194 having an apex 193 and 195 respectively; and obstructing member 110.
  • [0076]
    Intra-bronchial device 190 is generally similar in construction, operation, placement, and removal to the intra-bronchial device 150 of FIG. 9. Support structure 101 is a tubular member, preferably hypodermic needle tubing, or stainless steel, Nitinol, or other suitable material having a memory of its original shape and resiliency to return the material to that shape. Support members 102, 103, 104, 105, 106, and 108, and central support structure 109 may be formed by laser cutting a single piece of hypodermic needle tubing lengthwise, and bending the support members to a required shape. Support members 102, 103, 104, 105, 106, and 108 are generally similar to each other. Anchors 113, 114, 116, and 118 are disposed on support members 103, 104, 106, and 108, respectively, in any manner available in the art. Anchors 113-118 are disposed on support members 103, 104, 106, and 108 to be located proximally of obstructing member 110, and to engage an air passageway wall when intra-bronchial device 190 is deployed.
  • [0077]
    “U” shaped retracting member 192 is coupled to support members 103 and 104, and “U” shaped retracting member 194 is coupled to support members 106 and 108. “U” shaped retracting members 192 and 194 may be constructed of any material suitable for use within a patient, and may or may not be resilient as required by the particular embodiment. When intra-bronchial device 190 is fully deployed in an air passageway, the “U” shaped retracting members 192 and 194 are arranged opposite each other, and they partially overlap, with the apex of one lying within a space bounded by the “U” shape of the other member. In the deployed configuration, increasing the distance between apex 193 and apex 195 moves support member pairs 103-104 and 106-108 centrally.
  • [0078]
    In operation, when intra-bronchial device 190 is compressed for insertion into a catheter lumen and placement in an air passageway, support members 102, 103, 104, 105, 106, and 108 are collapsed centrally into a first configuration. This causes the anchor ends 123, 124, 126 and 128 to move centrally.
  • [0079]
    When intra-bronchial device 190 is deployed from the catheter lumen, the memory and resiliency of the support member pairs 103,104 and 106,108 impart a force that moves the anchors 113 and 114, and 116 and 118, and their anchor ends 123 and 124, and 126 and 128 into a second configuration, which is the deployed configuration to engage air passageway wall. In addition, deployment of intra-bronchial device 190 may include a step of forcibly decreasing the distance between apexes 193 and 195 to forcibly move the anchors 113 and 114, and 116 and 118 into engagement with the wall of the air passageway. While the anchors 113 and 114, and 116 and 118 of this embodiment do not include stops, the expansive or peripheral movement of the anchors will be limited by the interior surface of obstructing member 110. This may limit the piercing of the air passageway wall by anchors 113 and 114, and 116 and 118.
  • [0080]
    In an alternative embodiment, support member pairs 103,104 and 106,108 may be compressed for insertion into a catheter lumen by a device that increases the distance between apex 193 and apex 195. Such a device could be a tool with spreading jaws, or a tapered member inserted between the apexes. The device could be left in engagement after insertion into the catheter, and then withdrawn to allow support member pairs 103-104 and 106-108 to move apart and engage their anchors into the wail of the air passageway.
  • [0081]
    For removal, a retractor device is deployed from a catheter lumen to engage apex 193 and 195, and restrain intra-bronchial device 190. The retractor device may be any device that fits into the space defined by apexes 193 and 195 when the intra-bronchial device 190 is in its fully deployed configuration. The retractor device is used to increase the distance between apexes 193 and 195 until anchors 113, 114, 116, and 118, and anchor ends 123, 124, 126, and 128 are released from the air passageway wall. This collapses the anchors into to the first configuration for removal. Intra-bronchial device 190 is then further collapsed, and drawn into the catheter by pulling on the retractor device. This additionally collapses support structure 101 and obstructing member 110 into the first position so that they may be fully drawn into the catheter. Once drawn into the catheter, intra-bronchial device 190 may be removed from the air passageway and the patient.
  • [0082]
    [0082]FIG. 18 is a perspective view illustrating an alternative embodiment of a removable intra-bronchial device 200 with both distal and proximal anchors carried on corresponding peripheral portions of central support structure 109 in accord with the present invention. FIG. 19 is a side view of the device 200 of FIG. 18. Intra-bronchial device 200 is generally similar in construction, placement, and operation to intra-bronchial device 150 of FIGS. 9-11. Intra-bronchial device 200 is removed in the manner described in conjunction with FIG. 7. Intra-bronchial device 200 differs from intra-bronchial device 150 in that the central support structure 109 carries distal anchors in addition to the proximal anchors of device 150. Intra-bronchial device 200 includes distal anchors 212, 213, 214, 216, and 218; anchor ends 222, 223, 224, 226, and 228; and stops 252, 253, 254, 256, and 258. Intra-bronchial device 200 also include two more proximal anchors than device 150, which are proximal anchors 113 and 118; anchor ends 123 and 128, and stops 153 and 158.
  • [0083]
    The central support structure 109 of support structure 101 extends both distally and proximally of obstructing member 110, and carries both the proximal anchors 112, 113, 114, 116, and 118 and distal anchors 212, 213, 214, 216, and 218. The support structure 101 also includes support members 102, 103, 104, 106, and 108. Because of the perspective of FIGS. 18 and 19, several of the anchor members and several of the support members are not visible. Intra-bronchial device 200 is expected to provide additional anchoring force compared to the other embodiments disclosed herein.
  • [0084]
    Although the present invention has been described in considerable detail with reference to certain preferred embodiments, other embodiments are possible. Therefore, the spirit or scope of the appended claims should not be limited to the description of the embodiments contained herein. It is intended that the invention resides in the claims hereinafter appended.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2981254 *Nov 12, 1957Apr 25, 1961Vanderbilt Edwin GApparatus for the gas deflation of an animal's stomach
US3540431 *Apr 4, 1968Nov 17, 1970Kazi Mobin UddinCollapsible filter for fluid flowing in closed passageway
US3657744 *May 8, 1970Apr 25, 1972Univ MinnesotaMethod for fixing prosthetic implants in a living body
US3760808 *Dec 1, 1969Sep 25, 1973Bleuer KTampon applicator assembly
US3788327 *Mar 30, 1971Jan 29, 1974Donowitz HSurgical implant device
US3874388 *Feb 12, 1973Apr 1, 1975Ochsner Med Found AltonShunt defect closure system
US4014318 *May 22, 1975Mar 29, 1977Dockum James MCirculatory assist device and system
US4086665 *Dec 16, 1976May 2, 1978Thermo Electron CorporationArtificial blood conduit
US4212463 *Feb 17, 1978Jul 15, 1980Pratt Enoch BHumane bleeder arrow
US4250873 *Apr 17, 1978Feb 17, 1981Richard Wolf GmbhEndoscopes
US4302854 *Jun 4, 1980Dec 1, 1981Runge Thomas MElectrically activated ferromagnetic/diamagnetic vascular shunt for left ventricular assist
US4619246 *May 20, 1985Oct 28, 1986William Cook, Europe A/SCollapsible filter basket
US4681110 *Dec 2, 1985Jul 21, 1987Wiktor Dominik MCatheter arrangement having a blood vessel liner, and method of using it
US4710192 *Oct 17, 1986Dec 1, 1987Liotta Domingo SDiaphragm and method for occlusion of the descending thoracic aorta
US4727873 *Nov 26, 1986Mar 1, 1988Mobin Uddin KaziEmbolus trap
US4732152 *Dec 5, 1985Mar 22, 1988Medinvent S.A.Device for implantation and a method of implantation in a vessel using such device
US4759758 *Dec 7, 1984Jul 26, 1988Shlomo GabbayProsthetic heart valve
US4795449 *Aug 4, 1986Jan 3, 1989Hollister IncorporatedFemale urinary incontinence device
US4808183 *Jun 3, 1980Feb 28, 1989University Of Iowa Research FoundationVoice button prosthesis and method for installing same
US4819664 *Feb 17, 1988Apr 11, 1989Stefano NazariDevice for selective bronchial intubation and separate lung ventilation, particularly during anesthesia, intensive therapy and reanimation
US4830003 *Jun 17, 1988May 16, 1989Wolff Rodney GCompressive stent and delivery system
US4832680 *Jul 3, 1986May 23, 1989C.R. Bard, Inc.Apparatus for hypodermically implanting a genitourinary prosthesis
US4846836 *Oct 3, 1988Jul 11, 1989Reich Jonathan DArtificial lower gastrointestinal valve
US4850999 *May 26, 1981Jul 25, 1989Institute Fur Textil-Und Faserforschung Of StuttgartFlexible hollow organ
US4852568 *Dec 28, 1987Aug 1, 1989Kensey Nash CorporationMethod and apparatus for sealing an opening in tissue of a living being
US4877025 *Oct 6, 1988Oct 31, 1989Hanson Donald WTracheostomy tube valve apparatus
US4934999 *Jul 28, 1988Jun 19, 1990Paul BaderClosure for a male urethra
US4968294 *Feb 9, 1989Nov 6, 1990Salama Fouad AUrinary control valve and method of using same
US5061274 *Dec 4, 1989Oct 29, 1991Kensey Nash CorporationPlug device for sealing openings and method of use
US5116360 *Dec 27, 1990May 26, 1992Corvita CorporationMesh composite graft
US5116564 *Oct 10, 1989May 26, 1992Josef JansenMethod of producing a closing member having flexible closing elements, especially a heart valve
US5123919 *Nov 21, 1991Jun 23, 1992Carbomedics, Inc.Combined prosthetic aortic heart valve and vascular graft
US5151105 *Oct 7, 1991Sep 29, 1992Kwan Gett CliffordCollapsible vessel sleeve implant
US5158548 *Jul 24, 1991Oct 27, 1992Advanced Cardiovascular Systems, Inc.Method and system for stent delivery
US5161524 *Aug 2, 1991Nov 10, 1992Glaxo Inc.Dosage inhalator with air flow velocity regulating means
US5283063 *Jan 31, 1992Feb 1, 1994Eagle VisionPunctum plug method and apparatus
US5304199 *Jan 4, 1993Apr 19, 1994Gene E. Myers Enterprises, Inc.Apparatus for arterial total occlusion plaque separation
US5306234 *Mar 23, 1993Apr 26, 1994Johnson W DudleyMethod for closing an atrial appendage
US5314473 *Jan 5, 1993May 24, 1994Godin Norman JProsthesis for preventing gastric reflux into the esophagus
US5352240 *May 31, 1989Oct 4, 1994Promedica International, Inc.Human heart valve replacement with porcine pulmonary valve
US5358518 *Jan 25, 1993Oct 25, 1994Sante CamilliArtificial venous valve
US5366478 *Jul 27, 1993Nov 22, 1994Ethicon, Inc.Endoscopic surgical sealing device
US5382261 *Sep 1, 1992Jan 17, 1995Expandable Grafts PartnershipMethod and apparatus for occluding vessels
US5392775 *Mar 22, 1994Feb 28, 1995Adkins, Jr.; Claude N.Duckbill valve for a tracheostomy tube that permits speech
US5409019 *Nov 3, 1993Apr 25, 1995Wilk; Peter J.Coronary artery by-pass method
US5453090 *Mar 1, 1994Sep 26, 1995Cordis CorporationMethod of stent delivery through an elongate softenable sheath
US5509900 *Oct 15, 1993Apr 23, 1996Kirkman; Thomas R.Apparatus and method for retaining a catheter in a blood vessel in a fixed position
US5549626 *Dec 23, 1994Aug 27, 1996New York Society For The Ruptured And Crippled Maintaining The Hospital For Special SurgeryVena caval filter
US5603698 *Aug 23, 1995Feb 18, 1997Boston Scientific CorporationProsthesis delivery system
US5755770 *Jan 31, 1995May 26, 1998Boston Scientific CorporatiionEndovascular aortic graft
US5797960 *Apr 20, 1995Aug 25, 1998Stevens; John H.Method and apparatus for thoracoscopic intracardiac procedures
US5803078 *May 26, 1995Sep 8, 1998Brauner; Mark E.Methods and apparatus for intrapulmonary therapy and drug administration
US5851232 *Mar 15, 1997Dec 22, 1998Lois; William A.Venous stent
US5855601 *Jun 21, 1996Jan 5, 1999The Trustees Of Columbia University In The City Of New YorkArtificial heart valve and method and device for implanting the same
US5925063 *Sep 26, 1997Jul 20, 1999Khosravi; FarhadCoiled sheet valve, filter or occlusive device and methods of use
US5954636 *Jul 15, 1997Sep 21, 1999Schwartz; Roy E.Pediatric endotracheal tube with bronchial blocker and method for selectively blocking respiratory airflow to a pediatric patient's lung
US5954766 *Sep 16, 1997Sep 21, 1999Zadno-Azizi; Gholam-RezaBody fluid flow control device
US6149664 *Aug 27, 1998Nov 21, 2000Micrus CorporationShape memory pusher introducer for vasoocclusive devices
US6174323 *Jun 5, 1998Jan 16, 2001Broncus Technologies, Inc.Method and assembly for lung volume reduction
US6238334 *Nov 3, 1998May 29, 2001Cardio Technologies, Inc.Method and apparatus for assisting a heart to pump blood
US6258100 *Oct 10, 2000Jul 10, 2001Spiration, Inc.Method of reducing lung size
US6267775 *Mar 6, 2000Jul 31, 2001Schneider (Usa) Inc.Self-expanding medical device for centering radioactive treatment sources in body vessels
US6287290 *Jul 2, 1999Sep 11, 2001PulmonxMethods, systems, and kits for lung volume reduction
US6287334 *Dec 17, 1997Sep 11, 2001Venpro CorporationDevice for regulating the flow of blood through the blood system
US6293951 *Aug 24, 1999Sep 25, 2001Spiration, Inc.Lung reduction device, system, and method
US6328689 *Mar 23, 2000Dec 11, 2001Spiration, Inc.,Lung constriction apparatus and method
US6398775 *Oct 21, 1999Jun 4, 2002PulmonxApparatus and method for isolated lung access
US6439233 *Feb 1, 2000Aug 27, 2002ADEVA Medical Gesellschaft für Entwicklung und Vertrieb von Medizinischen Implantat-Artikeln mbHTracheal stoma valve
US6447530 *Nov 25, 1997Sep 10, 2002Scimed Life Systems, Inc.Atraumatic anchoring and disengagement mechanism for permanent implant device
US6488673 *Jul 8, 1999Dec 3, 2002Broncus Technologies, Inc.Method of increasing gas exchange of a lung
US6527761 *Oct 27, 2000Mar 4, 2003Pulmonx, Inc.Methods and devices for obstructing and aspirating lung tissue segments
US6558429 *Mar 26, 2001May 6, 2003Reflux CorporationPerorally insertable gastroesophageal anti-reflux valve prosthesis and tool for implantation thereof
US6585639 *Oct 27, 2000Jul 1, 2003PulmonxSheath and method for reconfiguring lung viewing scope
US6592594 *Oct 25, 2001Jul 15, 2003Spiration, Inc.Bronchial obstruction device deployment system and method
US6629951 *Jul 18, 2001Oct 7, 2003Broncus Technologies, Inc.Devices for creating collateral in the lungs
US6679264 *Mar 4, 2000Jan 20, 2004Emphasys Medical, Inc.Methods and devices for use in performing pulmonary procedures
US6694979 *Mar 2, 2001Feb 24, 2004Emphasys Medical, Inc.Methods and devices for use in performing pulmonary procedures
US20010037808 *Mar 2, 2001Nov 8, 2001Deem Mark E.Methods and devices for use in performing pulmonary procedures
US20010051799 *Apr 20, 2001Dec 13, 2001Ingenito Edward P.Tissue volume reduction
US20010056274 *Jul 2, 2001Dec 27, 2001Perkins Rodney A.Methods, systems, and kits for lung volume reduction
US20020062120 *Dec 13, 2001May 23, 2002PulmonxMethods, systems, and kits for lung volume reduction
US20020077593 *Feb 11, 2002Jun 20, 2002PulmonxApparatus and method for isolated lung access
US20020112729 *Feb 21, 2001Aug 22, 2002Spiration, Inc.Intra-bronchial obstructing device that controls biological interaction with the patient
US20020147462 *Sep 12, 2001Oct 10, 2002Closure Medical CorporationBronchial occlusion method and apparatus
US20030013935 *Jul 10, 2001Jan 16, 2003Spiration, Inc.Constriction device viewable under X ray fluoroscopy
US20030024527 *Aug 3, 2001Feb 6, 2003Integrated Vascular Systems, Inc.Lung assist apparatus and methods for use
US20030050648 *Sep 11, 2001Mar 13, 2003Spiration, Inc.Removable lung reduction devices, systems, and methods
US20030070682 *Oct 10, 2002Apr 17, 2003Wilson Peter M.Bronchial flow control devices and methods of use
US20030083671 *Oct 25, 2001May 1, 2003Spiration, Inc.Bronchial obstruction device deployment system and method
US20030154988 *Jun 21, 2002Aug 21, 2003Spiration, Inc.Intra-bronchial device that provides a medicant intra-bronchially to the patient
US20030158515 *Dec 11, 2002Aug 21, 2003Spiration, Inc.Device and method for intra-bronchial provision of a therapeutic agent
US20030167065 *Mar 1, 2002Sep 4, 2003Arvik Enterprises, LlcBlood vessel occlusion device
US20030180922 *May 8, 2002Sep 25, 2003Genentech, Inc.Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030183235 *Apr 17, 2003Oct 2, 2003Spiration, Inc.Bronchial obstruction device deployment system and method
US20030195385 *Apr 16, 2002Oct 16, 2003Spiration, Inc.Removable anchored lung volume reduction devices and methods
US20030212412 *May 9, 2002Nov 13, 2003Spiration, Inc.Intra-bronchial obstructing device that permits mucus transport
US20040039250 *May 28, 2003Feb 26, 2004David TholfsenGuidewire delivery of implantable bronchial isolation devices in accordance with lung treatment
US20040243140 *May 18, 2004Dec 2, 2004Alferness Clifton A.Collapsible intra-bronchial valve devices
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US7451765Jul 1, 2005Nov 18, 2008Mark AdlerIntra-bronchial apparatus for aspiration and insufflation of lung regions distal to placement or cross communication and deployment and placement system therefor
US7682332Jun 30, 2004Mar 23, 2010Portaero, Inc.Methods to accelerate wound healing in thoracic anastomosis applications
US7686013Feb 12, 2008Mar 30, 2010Portaero, Inc.Variable resistance pulmonary ventilation bypass valve
US7691151Oct 24, 2006Apr 6, 2010Spiration, Inc.Articulable Anchor
US7726305Feb 12, 2008Jun 1, 2010Portaero, Inc.Variable resistance pulmonary ventilation bypass valve
US7753052Feb 6, 2008Jul 13, 2010Portaero, Inc.Intra-thoracic collateral ventilation bypass system
US7757692Apr 22, 2009Jul 20, 2010Spiration, Inc.Removable lung reduction devices, systems, and methods
US7789083Jan 31, 2008Sep 7, 2010Portaero, Inc.Intra/extra thoracic system for ameliorating a symptom of chronic obstructive pulmonary disease
US7811274Apr 27, 2004Oct 12, 2010Portaero, Inc.Method for treating chronic obstructive pulmonary disease
US7824366Dec 10, 2004Nov 2, 2010Portaero, Inc.Collateral ventilation device with chest tube/evacuation features and method
US7828789Apr 7, 2008Nov 9, 2010Portaero, Inc.Device and method for creating a localized pleurodesis and treating a lung through the localized pleurodesis
US7842061Dec 23, 2003Nov 30, 2010Spiration, Inc.Methods of achieving lung volume reduction with removable anchored devices
US7875048Sep 3, 2004Jan 25, 2011Spiration, Inc.One-way valve devices for anchored implantation in a lung
US7896008Aug 6, 2007Mar 1, 2011Portaero, Inc.Lung reduction system
US7909803Feb 18, 2009Mar 22, 2011Portaero, Inc.Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease
US7927324Feb 18, 2009Apr 19, 2011Portaero, Inc.Aspirator and method for pneumostoma management
US7931641Feb 21, 2008Apr 26, 2011Portaero, Inc.Visceral pleura ring connector
US7942931Aug 15, 2005May 17, 2011Spiration, Inc.Device and method for intra-bronchial provision of a therapeutic agent
US8021320Feb 18, 2009Sep 20, 2011Portaero, Inc.Self-sealing device and method for delivery of a therapeutic agent through a pneumostoma
US8021385Jul 19, 2007Sep 20, 2011Spiration, Inc.Removable anchored lung volume reduction devices and methods
US8029492Apr 7, 2008Oct 4, 2011Portaero, Inc.Method for treating chronic obstructive pulmonary disease
US8043301Apr 10, 2009Oct 25, 2011Spiration, Inc.Valve loader method, system, and apparatus
US8062315Feb 12, 2008Nov 22, 2011Portaero, Inc.Variable parietal/visceral pleural coupling
US8079368Mar 10, 2010Dec 20, 2011Spiration, Inc.Bronchoscopic lung volume reduction method
US8104474Aug 23, 2005Jan 31, 2012Portaero, Inc.Collateral ventilation bypass system with retention features
US8136230Oct 10, 2008Mar 20, 2012Spiration, Inc.Valve loader method, system, and apparatus
US8163034Feb 21, 2008Apr 24, 2012Portaero, Inc.Methods and devices to create a chemically and/or mechanically localized pleurodesis
US8177805Aug 4, 2011May 15, 2012Spiration, Inc.Removable anchored lung volume reduction devices and methods
US8220460Nov 19, 2004Jul 17, 2012Portaero, Inc.Evacuation device and method for creating a localized pleurodesis
US8231581Jan 25, 2011Jul 31, 2012Portaero, Inc.Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease
US8252003Feb 18, 2009Aug 28, 2012Portaero, Inc.Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US8257381Dec 15, 2010Sep 4, 2012Spiration, Inc.One-way valve devices for anchored implantation in a lung
US8323230Jan 20, 2010Dec 4, 2012Portaero, Inc.Methods and devices to accelerate wound healing in thoracic anastomosis applications
US8336540Feb 12, 2009Dec 25, 2012Portaero, Inc.Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease
US8347880Feb 18, 2009Jan 8, 2013Potaero, Inc.Pneumostoma management system with secretion management features for treatment of chronic obstructive pulmonary disease
US8347881Jan 8, 2010Jan 8, 2013Portaero, Inc.Pneumostoma management device with integrated patency sensor and method
US8348906Feb 18, 2009Jan 8, 2013Portaero, Inc.Aspirator for pneumostoma management
US8365722Feb 18, 2009Feb 5, 2013Portaero, Inc.Multi-layer pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US8414655Jul 1, 2010Apr 9, 2013Spiration, Inc.Removable lung reduction devices, systems, and methods
US8430094Feb 18, 2009Apr 30, 2013Portaero, Inc.Flexible pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US8453637Feb 18, 2009Jun 4, 2013Portaero, Inc.Pneumostoma management system for treatment of chronic obstructive pulmonary disease
US8453638Feb 18, 2009Jun 4, 2013Portaero, Inc.One-piece pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US8454708Apr 5, 2010Jun 4, 2013Spiration, Inc.Articulable anchor
US8464708Feb 18, 2009Jun 18, 2013Portaero, Inc.Pneumostoma management system having a cosmetic and/or protective cover
US8474449Feb 18, 2009Jul 2, 2013Portaero, Inc.Variable length pneumostoma management system for treatment of chronic obstructive pulmonary disease
US8475389Jun 8, 2010Jul 2, 2013Portaero, Inc.Methods and devices for assessment of pneumostoma function
US8491602Feb 18, 2009Jul 23, 2013Portaero, Inc.Single-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease
US8506577Jul 6, 2012Aug 13, 2013Portaero, Inc.Two-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease
US8518053Feb 11, 2010Aug 27, 2013Portaero, Inc.Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US8647392Apr 26, 2012Feb 11, 2014Spiration, Inc.Articulable anchor
US8795241May 13, 2011Aug 5, 2014Spiration, Inc.Deployment catheter
US8926647Mar 29, 2013Jan 6, 2015Spiration, Inc.Removable anchored lung volume reduction devices and methods
US8956319Jul 20, 2012Feb 17, 2015Spiration, Inc.One-way valve devices for anchored implantation in a lung
US8974484Mar 6, 2013Mar 10, 2015Spiration, Inc.Removable lung reduction devices, systems, and methods
US8974527Mar 29, 2013Mar 10, 2015Spiration, Inc.Bronchoscopic repair of air leaks in a lung
US9198669Dec 13, 2013Dec 1, 2015Spiration, Inc.Articulable anchor
US9326873Dec 6, 2011May 3, 2016Spiration, Inc.Valve loader method, system, and apparatus
US9622752Mar 6, 2015Apr 18, 2017Spiration, Inc.Bronchoscopic repair of air leaks in a lung
US20030050648 *Sep 11, 2001Mar 13, 2003Spiration, Inc.Removable lung reduction devices, systems, and methods
US20030212412 *May 9, 2002Nov 13, 2003Spiration, Inc.Intra-bronchial obstructing device that permits mucus transport
US20040210248 *Mar 12, 2003Oct 21, 2004Spiration, Inc.Apparatus, method and assembly for delivery of intra-bronchial devices
US20070232992 *Oct 24, 2006Oct 4, 2007James KutskoArticulable anchor
US20150305749 *Dec 23, 2014Oct 29, 2015Spiration, Inc.Removable anchored lung volume reduction devices and methods
WO2004080347A2Mar 12, 2004Sep 23, 2004Spiration Inc.Apparatus, method and assembly for delivery of intra-bronchial devices
WO2015153500A1 *Mar 30, 2015Oct 8, 2015Spiration, Inc.Simulated valve device for airway
Classifications
U.S. Classification606/191
International ClassificationA61F2/04, B05D7/14, A61M29/00, A61M15/00, A61F2/24, A61M16/00
Cooperative ClassificationA61B2017/00809, A61B17/12172, A61F2002/043, A61F2/24, A61B17/12104
European ClassificationA61B17/12P5A, A61B17/12P7W1, A61F2/24
Legal Events
DateCodeEventDescription
Jul 15, 2002ASAssignment
Owner name: SPIRATION, INC., WASHINGTON
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DILLARD, DAVID H.;GONZALEZ, HUGO X.;YI, SEUNG;AND OTHERS;REEL/FRAME:013083/0253;SIGNING DATES FROM 20020521 TO 20020528
Mar 25, 2003ASAssignment
Owner name: SPIRATION, INC., WASHINGTON
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ALFERNESS, CLIFTON A.;REEL/FRAME:013877/0671
Effective date: 20030317